Thaci, D., K. Papp, K. Gordon, A. Morita, M. Gooderham, P. Foley, E. Alemano, R. Kisa, Y. Elbez, H. Ren, and S. Banerjee. “An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Improves Quality of Life in Psoriasis: Results from a Phase 2 Study”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S12, doi:10.25251/skin.3.supp.12.